|
|
| Line 45: |
Line 45: |
| **Ustekinumab (Stelara) | | **Ustekinumab (Stelara) |
| **Vedolizumab (Entyvio) | | **Vedolizumab (Entyvio) |
| | '''Do not include''' |
| | * hydroxychloroquine - as per task meeting 2022-04-20 it is an immune modulator, but not very immunosuppressive |
| }} | | }} |
Latest revision as of 12:32, 2022 April 20
This template provides a list of immunosuppressive drugs to the various pages that reference these (see Special:WhatLinksHere/Template:List_of_immunosuppressive_drugs). To user:
{{List of immunosuppressive drugs}}
| List of immunosuppressive drugs
|
- Used to treat an increasing variety of conditions: immune-mediated (RA, UC, Crohn's, lupus, MS, psoriasis, etc); after organ transplant.
- Only considered immunosuppressive if given systemically (po, im or iv)
- Corticosteroids (unlike all the others, these only count if > a given daily dose and used for at least 2 weeks prior to admission)
- Dexamethasone: >0.25 mg/day
- Hydrocortisone: >40 mg/day
- Prednisone (methyl-prednisolone): >10 mg/day
- Prednisolone: >8 mg/day
- Cancer chemotherapy -- includes any agents, if received within the past 6 months
- Nonsteroidal immunosuppressives -- includes any of these, if received within the past 1 month
- Abatacept (Orencia)
- Azathioprine (Imuran)
- Adalimumab (Humira)
- Anakinra (Kineret)
- Basiliximab (Simulect)
- Certolizumab (Cimzia)
- Cyclophosphamide (Cytoxan)
- Cyclosporine
- Daclizumab (Zinbryta)
- Etanercept (Enbrel)
- Everolimus (Afinitor, Zortress)
- Golimumag (Simponi)
- Infliximab (Remicade)
- Ixekizumab (Taltz)
- Leflunomide (Arava)
- Lenalidomide
- Methotrexate
- Mycophenolate (CellCept)
- Natalizumab (Tysabri)
- Rituximab (Rituxan)
- Secukinumab (Cosentyx)
- Sirolimus (Rapasumne)
- Tacrolimus (Prograf)
- Tocilizumab (Actemra)
- Tofacitinib (Xeljanz)
- Ustekinumab (Stelara)
- Vedolizumab (Entyvio)
Do not include
- hydroxychloroquine - as per task meeting 2022-04-20 it is an immune modulator, but not very immunosuppressive
|